Form 4: Ginkgo Bioworks Executive Steven P. Coen Reports Stock Transactions

Ginkgo Bioworks' Chief Accounting Officer, Steven P. Coen, executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including sales to cover tax obligations.

Summary

• Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reported several transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• On January 3, 2025, Coen acquired 587 shares of Class A Common Stock and 587 RSUs, and another 156 shares of Class A Common Stock and 156 RSUs.
• On January 6, 2025, Coen sold 324 shares of Class A Common Stock at a price of $11.718 per share.
• These sales were to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units.
• Following these transactions, Coen directly owns 7,288 shares of Class A Common Stock and 5,939 RSUs.

Sentiment

Score: 5

Explanation: The document is a routine filing of stock transactions by an executive, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine SEC Form 4 filing, which is standard for company insiders reporting transactions in their company's stock. It is a normal part of corporate governance and transparency.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and Ginkgo Bioworks' filing is consistent with these requirements.
• The transactions reported are typical for executives who receive stock-based compensation, often involving sales to cover tax obligations upon vesting.
• Similar filings can be seen from executives at comparable companies such as Amyris, Zymergen (now part of Ginkgo), and other biotech firms.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and related to executive compensation.
• The sales to cover tax obligations do not represent a change in the executive's long-term view of the company.

Key Dates

Keywords

Ginkgo Bioworks, Steven P. Coen, Class A Common Stock, Restricted Stock Units, RSU, stock transactions, insider trading, tax withholding